Previous 10 | Next 10 |
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 29, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...
Boston, Massachusetts--(Newsfile Corp. - August 27, 2021) - The Massachusetts office of Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN), a late-stage clinical compa...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 26, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is ...
Boston, Massachusetts--(Newsfile Corp. - August 25, 2021) - The Massachusetts office of Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN), a late-stage clinical compa...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cambridge, Massachusetts-based cancer researcher Sesen Bio (NASDAQ: SESN ) has had an action-packed August, to say the least. SESN stock has been a short-term trader’s paradise due to its volatility, but w...
Gainers: Takung Art (NYSE:TKAT) +48%. Triple-S Management (NYSE:GTS) +45%. KLX Energy (NASDAQ:KLXE) +25%. New Oriental Education (NYSE:EDU) +26%. SkyWater Technology (NASDAQ:SKYT) +25%. Sentage (NASDAQ:SNTG) +24%. Bio-Path Holdings (NASDAQ:BPTH) +20%. TuSimple (NASDAQ:TSP) +20%. CynergisTek (...
Palm Beach, FL – August 24, 2021 – FinancialNewsMedia.com News Commentary – Recently, approximately 1.2 million new liver cancer cases have been reporting around the world. The increasing intense research and development activities opposing dangerous disease...
The current FDA environment is under heavy scrutiny with much uncertainty. Sesen Bio's lead drug, Vicineum, received a complete response letter from the Agency which put tremendous pressure on the stock. The company is eager to conduct a Type A meeting with the FDA to discuss the ...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 21, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is ...
Sesen Bio (NASDAQ: SESN) had a tumultuous Friday. On a generally fine day for stocks, the company's shares fell by almost 10%. A clutch of law firms are coming for it, and investors are stepping away. On Friday, several fresh lawsuits against Sesen Bio were announced. As they we...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...